Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. (ZBH) is a medical device company specializing in orthopedic reconstructive products, with a dominant political signal being $128.5M in annual doctor payments (2023) and a single congressional trader executing 16 transactions in the last 12 months.
BusinessWhat ZBH does
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive products, including knee and hip implants, surgical equipment, and biologics. Revenue is generated through sales of joint replacement devices, sports medicine, extremities, trauma, craniomaxillofacial, and dental products. The company operates globally, with significant exposure to U.S. healthcare reimbursement policies and FDA regulation.
12 months past · 3 months futureZBH activity timeline
Executive Branch ConflictsZBH held by Trump-administration officials
Lifetime Government AwardsZBH federal contracts
ZBH doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding ZBH
Politicians Trading ZBHMembers of Congress with recent ZBH positions
Congressional TradesWho in Congress is trading ZBH
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
Bills Affecting ZBHLive legislation impacting this stock
Political ProfileWhere ZBH sits in Washington
[object Object]
STRUCTURAL: High regulatory density (85 score) due to healthcare sector and physician payment exposure ($128.5M in 2023). EVIDENTIARY: Single active congressional trader (16 trades) and executive branch holding (Trump OGE disclosure). Net: No lobbying or donations, but evidentiary trading and high doctor payments create mixed signals.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Physician payment transparency and potential anti-kickback scrutinyHHS/OIG"get_political_influence.doctor_payments shows $128.5M in 2023 across 30,992 payments, indicating high volume of financial relationships with physicians."
-
Reimbursement changes for orthopedic devices under MedicareCMS"Recent bill_impacts array includes 8 healthcare bills with low but non-zero impact_ratios, suggesting regulatory density."
Regulatory opportunities
-
Potential for favorable coverage decisions for new device technologiesCMS"get_political_influence.doctor_payments indicate ongoing physician engagement, which may support product adoption."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
Live signals + predictions for ZBH — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades ZBH
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord